Clinical features and molecular modelling of novel MPZ mutations in demyelinating and axonal neuropathies
Open Access
- 18 March 2009
- journal article
- research article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 17 (9) , 1129-1134
Abstract
Mutations in the myelin protein zero (MPZ) gene have been associated with different Charcot–Marie–Tooth disease (CMT) phenotypes, including classical demyelinating CMT1B and the axonal form of the disease (CMT2). The MPZ role in the pathogenesis of both demyelinating and axonal inherited neuropathies was evaluated in the Italian population by screening a cohort of 214 patients with CMT1 or CMT2. A MPZ mutation frequency of 7.9% in demyelinating cases and of 4.8% in axonal cases was observed. In the total cohort (264 patients), including those with mutations in other genes, a mutation frequency of 5.8% (7/121) in demyelinating cases and 4.2% (6/143) in axonal cases was found. Three novel MPZ mutations, two missense (p.Ser111Cys, p.Thr124Ala) and one frameshift (p.Tyr145fs) were found, and a molecular modelling approach was used to test the effects of these mutations on the protein structure. Electrostatic distribution changes within the protein, caused by the amino acid substitution, fit in with phenotypes presented by patients herein described. Our findings suggest that the clinical features associated with MPZ mutations depend partly on the nature of amino acid change and that molecular modelling may provide useful support, based on effects on secondary and tertiary protein structure, to predict the phenotype associated with MPZ mutations.Keywords
This publication has 20 references indexed in Scilit:
- Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutationsHuman Molecular Genetics, 2008
- Transmembrane Domain of Myelin Protein Zero Can Form Dimers: Possible Implications for Myelin ConstructionBiochemistry, 2007
- Major myelin protein gene (P0) mutation causes a novel form of axonal degenerationJournal of Comparative Neurology, 2006
- Normal expression of myelin protein zero with frame‐shift mutation correlates with mild phenotypeJournal of the Peripheral Nervous System, 2006
- Different Intracellular Pathomechanisms Produce DiverseMyelin Protein ZeroNeuropathies in Transgenic MiceJournal of Neuroscience, 2006
- Mutations in the cytoplasmic domain of P0 reveal a role for PKC-mediated phosphorylation in adhesion and myelinationJournal of Cell Biology, 2001
- Novel MPZ Mutation In A Sporadic CMT PatientJournal of the Peripheral Nervous System, 2001
- Charcot‐Marie‐Tooth Neuropathy Type 2 and P0 Point Mutations: Two Novel Amino Acid Substitutions (Asp61Gly; Tyr119Cys) and a Possible “Hotspot” on Thr124MetBrain Pathology, 2000
- Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axonsCell, 1992
- Congenital hypomyelination neuropathy with arthrogryposis multiplex congenitaAnnals of Neurology, 1992